Latest filing published 10 Jun 2021 for Calyxt, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Sarah Reiter: trading record in brief
Filings by Sarah Reiter span 2 companies, the busiest being Arcadia Biosciences, Inc. and Cibus, Inc. The record holds 5 filings, for trades running from 10 September 2019 to 8 June 2021.
The open-market record is one-sided, with 4 purchases worth €17k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant.
A typical purchase (the median) is worth €4,458.
On 10 June 2021 came the latest disclosure, a share grant in Cibus, Inc. The most recent open-market purchase was published on 4 February 2020, 2,469 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sarah Reiter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,601 shares0Common StockSEC:0001615594-21-000072:0
1 of 1 declaration
